Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 69Neoplasms 32Prostatic Neoplasms 30Lung Neoplasms 24Head and Neck Neoplasms 20Neoplasm Metastasis 15Motor Activity 14Colorectal Neoplasms 14Multiple Myeloma 13Ovarian Neoplasms 11Gastrointestinal Neoplasms 11Fatigue 10Carcinoma, Non-Small-Cell Lung 10cyclopia sequence 8Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Pain 8Lymphoma 8Anxiety Disorders 8Smoking Cessation 7Recurrence 7Neoplasms, Plasma Cell 7Esophageal Neoplasms 7Endometrial Neoplasms 7Carcinoma, Renal Cell 7Tobacco Use Cessation 6Rectal Neoplasms 6Oropharyngeal Neoplasms 6Leukemia 6Depression 6

Interventions

pembrolizumab 3Paclitaxel 2relatlimab 1nintedanib 1lifileucel 1dabrafenib 1Vitamin D 1Temozolomide 1Surveys and Questionnaires 1Opdualag 1Nivolumab 1Ipilimumab 1Eye Movement Desensitization Reprocessing 1Electrochemotherapy 1Dacarbazine 1Cholecalciferol 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Melanoma, Cutaneous Malignant × Surveys and Questionnaires × Clear all
NCT00816374 2014-05-16

Tailored Intervention for Melanoma Patient's Families

Fox Chase Cancer Center

Phase NA Completed
553 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡